Company Search:
Advanced Search
Sponsored Links
Mast Therapeutics Inc Company Snapshot
Mast Therapeutics Inc operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Mast Therapeutics Inc with three other companies in this sector in the United States: Abeona Therapeutics Inc (2010 sales of $481,000.00 of which 100% was Advanced polymer), Catalyst Pharmaceuticals Inc ($488,958.00 of which 100% was Prescription Drugs), and Advaxis, Inc. ($508,481.00 of which 100% was License Fees & Grants).

Sales Analysis.
  Stock Performance Chart for Mast Therapeutics Inc
  Stock Data: Recent Stock Performance:
  Current Price (1/13/2017): .14
(Figures in U.S. Dollars)
1 Week 38.6%   13 Weeks 30.6%  
4 Weeks 71.4%   52 Weeks -65.3%  
Mast Therapeutics Inc Key Data:
  Ticker: MSTX Country: United States
  Exchanges: ASE Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2010 Sales 488,959
(Year Ending Jan 2011).
Employees: 28
  Currency: U.S. Dollars Market Cap: 32,661,395
  Fiscal Yr Ends: December Shares Outstanding: 238,230,454
  Share Type: Common Closely Held Shares: 172,500
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.